Market Cap

Lin BioScience, Inc. Market Capitalization:

TW$8.91 Billion

TWD as of Jan. 1, 2024

US$290.3 Million

business Lin BioScience, Inc. Company Profile

Lin BioScience, Inc. Main Stock Listing

TWSE: 6696

Market Capitalization History of Lin BioScience, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Lin BioScience, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$8.91 B -27.55%
Jan. 1, 2023 TW$12.29 B -19.10%
Jan. 1, 2022 TW$15.20 B 93.61%
Jan. 1, 2021 TW$7.85 B 119.04%
Jan. 1, 2020 TW$3.58 B 26.72%
Jan. 1, 2019 TW$2.83 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Lin BioScience, Inc. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Lin BioScience, Inc. has the following listings and related stock indices.


Stock: TWSE: 6696

Stock: MYX: 5789

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.